Overview

Clinical Application of Near-infrared Fluorescence Guided Localization on Breast Surgery in Breast Cancer

Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
0
Participant gender:
Female
Summary
Near-infrared (NIR) fluorescence imaging using indocyanine green (ICG) has been used for breast cancer surgery such as sentinel lymph node (SLN) mapping and breast cancer localization. In this study, our hypothesis are as following: 1. As inject only indocyanine green (ICG), it provide the surgeon visual guidance to ensure better outcome. 2. indocyanine green (ICG) permitted accurate preoperative and intraoperative detection of the SLNs as well as nonpalpable benign brest lesion in patients with breast cancer.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
National Cancer Center, Korea
Criteria
Inclusion Criteria:

- nonpalpable breast tumor ≤ 2cm in patients with breast cancer.

- patients who need breast biopsy as treatment for breast cancer.

- Eastern Cooperative Oncology Group Performance status 0 or 1

- consented patients with more than 20 years, less than 70 years

Exclusion Criteria:

- nonpalpable breast tumor ≥ 2cm in patients with breast cancer.

- pregnancy

- history of severe allergy to ICG(Indocyanine Green)

- iode hypersensitiveness